Fundraising Fox
Constellate Proteomics
1 known investors
Find your way into Constellate Proteomics
Sign up to see every warm intro you have to Constellate Proteomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Constellate Proteomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Constellate uses reversibly-binding affinity probes to read antibody samples one molecule at a time, resolving critical quality attributes (titre, glycosylation, aggregation, charge) from a single drop of crude supernatant in minutes rather than weeks. The resulting single-molecule data trains predictive "world models" of cell-line behaviour for antibody developers and CDMOs doing cell-line and process development.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Constellate Proteomics do?
- Constellate uses reversibly-binding affinity probes to read antibody samples one molecule at a time, resolving critical quality attributes (titre, glycosylation, aggregation, charge) from a single drop of crude supernatant in minutes rather than weeks. The resulting single-molecule data trains predictive "world models" of cell-line behaviour for antibody developers and CDMOs doing cell-line and process development.
- Who founded Constellate Proteomics?
- Constellate Proteomics was founded by Dennis de Beeld.
- Who are Constellate Proteomics's investors?
- Constellate Proteomics's investors include imec.istart.